Fertility and Sterility
Volume 94, Issue 3 , Pages 875-887, August 2010

Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure

  • Elpida Fragouli, Ph.D.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom
    • Reprogenetics UK, Oxford, United Kingdom
    • Corresponding Author InformationReprint requests: Elpida Fragouli, Ph.D., University of Oxford, Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, United Kingdom (FAX: + 011441865617677).
  • ,
  • Mandy Katz-Jaffe, Ph.D.

      Affiliations

    • Colorado Center for Reproductive Medicine, Lone Tree, Colorado
  • ,
  • Samer Alfarawati, M.S.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom
    • Reprogenetics UK, Oxford, United Kingdom
  • ,
  • John Stevens, B.S.

      Affiliations

    • Colorado Center for Reproductive Medicine, Lone Tree, Colorado
  • ,
  • Pere Colls, Ph.D.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • N-neka Goodall, B.A.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • Sophia Tormasi, B.S.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • Cristina Gutierrez-Mateo, Ph.D.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • Renata Prates, B.S.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • William B. Schoolcraft, M.D.

      Affiliations

    • Colorado Center for Reproductive Medicine, Lone Tree, Colorado
  • ,
  • Santiago Munne, Ph.D.

      Affiliations

    • Reprogenetics LLC, Livingston, New Jersey
  • ,
  • Dagan Wells, Ph.D.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom
    • Reprogenetics UK, Oxford, United Kingdom

Received 17 February 2009; received in revised form 7 April 2009; accepted 24 April 2009. published online 22 June 2009.

Objective

To identify and transfer cytogenetically normal embryos after screening all chromosomes of first and second polar bodies (PBs) or trophectoderm samples with the use of comparative genomic hybridization.

Design

Clinical research study.

Setting

In vitro fertilization clinic referring samples to a specialist preimplantation genetic diagnosis laboratory.

Patient(s)

Thirty-two couples with repeated implantation failure.

Intervention(s)

Zygotes from patients with repeated implantation failure and poor response to ovarian stimulation underwent PB biopsy. Patients with repeated implantation failure who were candidates for blastocyst transfer received trophectoderm biopsy. Zygotes or blastocysts were vitrified while chromosome analysis took place. Euploid embryos were transferred during a subsequent cycle.

Main Outcome Measure(s)

Cytogenetic status and implantation and pregnancy rates.

Result(s)

The oocyte and blastocyst aneuploidy rates were 65.5% and 45.2%, respectively. Abnormalities affecting all chromosomes were detected. Implantation and pregnancy rates for the patients with PB biopsy were 11.5% and 21.4%, respectively, whereas for patients receiving blastocyst analysis they were 58.3% and 69.2%.

Conclusion(s)

Initial results for patients of advanced maternal age (39.8 years) with repeated implantation failure and poor ovarian response were encouraging. However, further study is required to confirm whether or not screening is beneficial. Blastocyst analysis was associated with high pregnancy rates, suggesting that comprehensive chromosome screening may assist patients with repeated implantation failure capable of producing blastocysts in achieving pregnancies.

Key Words: Repeated implantation failure, oocyte, polar body, embryo, blastocyst, preimplantation genetic screening, comparative genomic hybridization, chromosome, aneuploidy, vitrification

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 E.F. has nothing to disclose. M.K.-J. has nothing to disclose. S.A. has nothing to disclose. J.S. has nothing to disclose. P.C. has nothing to disclose. N.G. has nothing to disclose. S.T. has nothing to disclose. C.G.-M. has nothing to disclose. R.P. has nothing to disclose. W.B.S. has nothing to disclose. S.M. has nothing to disclose. D.W. has nothing to disclose.

 D.W. is funded by the National Institute for Health Research Biomedical Research Centre Programme. The authors also received valuable support from the “Once Upon a Time Foundation.”

PII: S0015-0282(09)01078-4

doi:10.1016/j.fertnstert.2009.04.053

Fertility and Sterility
Volume 94, Issue 3 , Pages 875-887, August 2010